Siegel, A.
(2022).
 Rationale for Expanding the Use of Low-Dose Aspirin for Primary Cardiovascular Prevention during the COVID-19 Pandemic.
<em>Medical Research Archives, 10</em>(10).
doi:10.18103/mra.v10i10.3159